Skip to content

Anxiety Control by Erythrina Mulungu

Anxiety Control by Using Erythrina Mulungu in Mandibular Third Molars Extraction

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01948622
Enrollment
30
Registered
2013-09-23
Start date
2012-01-31
Completion date
2012-11-30
Last updated
2013-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Anxiety, Impacted Third Molar Tooth

Keywords

Anxiety, Third molar surgery, Blood pressure, Heart rate, Oxygen saturation

Brief summary

This study evaluated the effectiveness of the Erythrina mulungu in controlling anxiety in patients undergoing bilateral extraction of asymptomatic, impacted mandibular third molars.

Detailed description

: In this research, characterized as a randomized, double-blind, crossover study, 30 healthy volunteered patients (05 men and 25 women) aged 18 or older who received a capsule of 500mg of Mulungu Matusa ® or placebo, orally, one hour before the procedure were selected. The level of anxiety was assessed through questionnaires and physical parameters, such as blood pressure, heart rate and oxygen concentration. Data were collected, tabulated and analyzed by the following statistical tests: chi-square, t-test, ANOVA and Tukey test, Friedman, Fisher's exact test with significance level of 5%.

Interventions

500 mg/single dose/1 hour before dental surgery

DRUGPlacebo

500 mg/single dose/1 hour before dental surgery

Sponsors

University of Campinas, Brazil
CollaboratorOTHER
Liane Maciel de Almeida Souza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* indication of bilateral extraction of asymptomatic, impacted mandibular third molars

Exclusion criteria

* patients under the age of 18 * any general health problem based on the medical history and physical examination * history of use of any medication within 15 days before the beginning of the research * history of hypersensitivity to drugs, substances or materials used in this experiment * pregnancy or lactation * history of pericoronitis

Design outcomes

Primary

MeasureTime frameDescription
Changes in anxiety reportChange from baseline to 7 daysChanges in the subjects' anxiety level was observed by using a Modified Corah Dental Anxiety Scale in three times: at baseline, in the day of surgery and after 7 days of the procedure.

Secondary

MeasureTime frameDescription
Changes in blood pressureChange from baseline to 2 hoursblood pressure (mmHg) was measured before drug administration, 30 minutes after drug administration and during local anesthesia, incision, tooth removal and suturing.
Changes in heart rateChange from baseline to 2 hoursheart rate (bpm) was measured before drug administration, 30 minutes after drug administration and during local anesthesia, incision, tooth removal and suturing.
Changes in oxygen saturationChange from baseline to 2 hoursoxygen saturation (SpO2) was measured before drug administration, 30 minutes after drug administration and during local anesthesia, incision, tooth removal and suturing.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026